Atara Biotherapeutics Inc
NASDAQ:ATRA
Atara Biotherapeutics Inc
NASDAQ:ATRA
Price:
0.5299 USD
-2.91%
Market Closed
Updated:
May 13, 2024
Atara Biotherapeutics Inc
Depreciation & Amortization
|
Atara Biotherapeutics Inc
Depreciation & Amortization Peer Comparison
Comparables:
ABBV
GILD
AMGN
VRTX
REGN
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Atara Biotherapeutics Inc
NASDAQ:ATRA
|
Depreciation & Amortization
$4.8m
|
CAGR 3-Years
-17%
|
CAGR 5-Years
5%
|
CAGR 10-Years
N/A
|
|
|
Abbvie Inc
NYSE:ABBV
|
Depreciation & Amortization
$8.7B
|
CAGR 3-Years
10%
|
CAGR 5-Years
38%
|
CAGR 10-Years
26%
|
|
|
Gilead Sciences Inc
NASDAQ:GILD
|
Depreciation & Amortization
$2.7B
|
CAGR 3-Years
19%
|
CAGR 5-Years
13%
|
CAGR 10-Years
18%
|
|
|
Amgen Inc
NASDAQ:AMGN
|
Depreciation & Amortization
$4.6B
|
CAGR 3-Years
9%
|
CAGR 5-Years
18%
|
CAGR 10-Years
12%
|
|
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
Depreciation & Amortization
$181.3m
|
CAGR 3-Years
18%
|
CAGR 5-Years
20%
|
CAGR 10-Years
14%
|
|
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
Depreciation & Amortization
$435.6m
|
CAGR 3-Years
21%
|
CAGR 5-Years
22%
|
CAGR 10-Years
26%
|
See Also
What is Atara Biotherapeutics Inc's Depreciation & Amortization?
Depreciation & Amortization
4.8m
USD
4.8m
USD
Based on the financial report for Dec 31, 2023, Atara Biotherapeutics Inc's Depreciation & Amortization amounts to 4.8m USD.
What is Atara Biotherapeutics Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
5%
5%
Over the last year, the Depreciation & Amortization growth was -15%. The average annual Depreciation & Amortization growth rates for Atara Biotherapeutics Inc have been -17% over the past three years , 5% over the past five years .
You don't have any saved screeners yet
